Abstract
Hepatitis B reactivation following chemotherapy withdrawal may result in hepatitis, hepatic failure and death. We studied the clinical outcome and the causes of hepatic events of hepatitis B surface antigen positive recipients undergoing bone marrow transplantation. Twenty-four hepatitis B surface antigen patients were matched with 24 hepatitis B surface antigen negative patients for age, sex, CMV positive serology, underlying hematological disease and type of bone marrow transplantation. Post-BMT, there were 18 patients in the hepatitis B surface antigen positive group and four patients in the hepatitis B surface antigen negative group who suffered from hepatitis (P < 0.05). thirteen of the 18 hepatitis were related to hbv reactivation in the hepatitis b surface antigen positive group and none of the four hepatitis in the hepatitis b surface antigen negative group (P = 0.01). The hepatitis B surface antigen positive group also had an increased incidence of acute graft-versus-host disease of liver (6 vs 1, P = 0.03). However, there was no significant increase in the incidence of veno-occlusive disease (10 vs 7, P = 0.40) and persistent hepatitis (3 vs 0, P = 0.07) in the hepatitis B surface antigen positive group. Using the log-rank test, there was no significant difference in survival between the hepatitis B surface antigen positive and negative recipients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lau, G., Liang, R., Chiu, E. et al. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant 19, 795–799 (1997). https://doi.org/10.1038/sj.bmt.1700744
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700744
Keywords
This article is cited by
-
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
Hepatology International (2021)
-
Diagnosis, Management, and Prevention of Hepatitis B Reactivation
Current Hepatology Reports (2015)
-
Management of patients with hepatitis B who require immunosuppressive therapy
Nature Reviews Gastroenterology & Hepatology (2014)
-
Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors
Medical Oncology (2014)
-
HBV-related events after allogeneic hematopoetic stem cell transplantatıon in a center from Turkey
Annals of Hematology (2013)